Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
March 3, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2023 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2023 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
March 1, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
March 1, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
March 1, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
March 1, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
March 1, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
February 21, 2023 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 17, 2023 PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us